3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Recruiting
2
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Genitourinary
6
Sarcoma
3
Gynecologic
3
Gastrointestinal
3
Breast
3
Thoracic
1
Head & Neck
1
Conditions
Uterine Cervical Neoplasms
3
Endometrial Neoplasms
1
Interventions
Paclitaxel
74
pembrolizumab
59
Carboplatin
55
Bevacizumab
54
Specimen Handling
47
Magnetic Resonance Spectroscopy
38
Cisplatin
32
olaparib
28
Gemcitabine
25
liposomal doxorubicin
24
Biopsy
20
Taxes
18
Topotecan
17
Nivolumab
17
Doxorubicin
15
Cyclophosphamide
15
Immunoglobulin G
14
Disulfides
14
niraparib
12
fludarabine
12
lenvatinib
11
Surveys and Questionnaires
11
Letrozole
11
atezolizumab
10
Drug Therapy
10
durvalumab
9
Fulvestrant
9
Docetaxel
9
Brachytherapy
9
mirvetuximab soravtansine
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Radiation Dose Hypofractionation
×
Gynecologic
×
90 days
×
Clear all
NCT07605507
2026-05-26
HYPOCx-iRex
Siriraj Hospital
Phase NA
Active not recruiting
40 enrolled
NCT07595224
2026-05-19
PostOP HYPOCxE
Siriraj Hospital
Phase NA
Recruiting
120 enrolled
NCT07276360
2026-03-27
HypoRTCx-UG
Uganda Cancer Institute
Phase 2
Recruiting
278 enrolled